[1]
Jalil, N.J.A. et al. 2015. The Implication of the Polymorphisms of COX-1, UGT1A6, and CYP2C9 among Cardiovascular Disease (CVD) Patients Treated with Aspirin. Journal of Pharmacy & Pharmaceutical Sciences. 18, 3 (Sep. 2015), 474–483. DOI:https://doi.org/10.18433/J3FC7F.